Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2015
02/05/2015US20150037399 Novel use of pipoxolan and its pharmaceutical composition
02/05/2015US20150037398 Molecule mixture comprising an amphipathic molecule type a, which has a positive total charge in the hydrophilic range, and an amphipathic molecule type b and a polyphenol c, method for producing said molecule mixture and use thereof
02/05/2015US20150037396 Targeted Delivery of Anti-Fungal Agents
02/05/2015US20150037395 Transdermal hormone delivery system: compositions and mtehods
02/05/2015US20150037391 Local administration of gallium compositions to treat pain
02/05/2015US20150037388 Edible slow dissolving film for treating oral ulcerations
02/05/2015US20150037386 Compositions and methods for promoting bone formation
02/05/2015US20150037378 Anti-Microbial Formulations Containing Nitric Oxide
02/05/2015US20150037377 Substituted cellulose acetates and uses thereof
02/05/2015US20150037372 pH-Responsive High-Density Lipoprotein-Like Particle Complex
02/05/2015US20150037360 Lysosome-Cleavable Linker
02/05/2015US20150037357 Immune stimulation/metabolic inhibition as antitumor therapy
02/05/2015US20150037351 Novel therapeutic target for the prevention of tumour metastasis
02/05/2015US20150037341 Diagnostic and Therapeutic Method
02/05/2015US20150037336 Combination of hb-egf binding protein and egfr inhibitor
02/05/2015US20150037332 Treatment of metastic breast cancer
02/05/2015US20150037329 Method of reducing titers of antibodies specific for a therapeutic agent
02/05/2015US20150037325 Slit-robo signaling for diagnosis and treatment of kidney disease
02/05/2015US20150037320 Treatment of macrophage-related disorders
02/05/2015US20150037318 Treatment of multiple sclerosis with combination of laquinimod and flupirtine
02/05/2015US20150037313 Mixture of peptide-bound tryptophan and polypeptide-bound tryptophan
02/05/2015US20150037309 Preparation for improving the action of receptors
02/05/2015US20150037308 Pyrroloquinoline quinone alcohol adduct
02/05/2015US20150037295 Methods of inducing tissue regeneration
02/05/2015US20150037291 Compositions and methods for cell transplantation
02/05/2015US20150037282 D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
02/05/2015US20150037280 Substituted pyrazolone compounds and methods of use
02/05/2015US20150037276 Hydrocolloid composition and an article containing the same
02/05/2015US20150037275 Rifaximin complexes
02/05/2015US20150037263 Treatment of multiple sclerosis with combination of laquinimod and fingolimod
02/05/2015US20150037252 Method for the Treatment of a Solid Tumour
02/05/2015US20150037249 Uses of porous nanostructure in delivery
02/05/2015US20150034087 Low Dose Pharmaceutical Composition Comprising Zanamivir
02/05/2015DE102013012800A1 Verwendung eienr Naturstoffmischung zur Bekämpfung von neurodegenerativen Erkrankungen bei Mensch und Tier Use eienr natural product mix to combat neurodegenerative diseases in humans and animals
02/04/2015EP2832860A1 Nucleic acid molecule capable of inhibiting expression of periostin gene, method for inhibiting expression of periostin gene, and use of said nucleic acid molecule
02/04/2015EP2832740A1 SALT OF 1-(2-DEOXY-2-FLUORO-4-THIO-beta-D-ARABINOFURANOSYL)CYTOSINE
02/04/2015EP2832734A1 Heterocyclic compound
02/04/2015EP2832733A1 4-alkanoylamino-3-pyrazolone derivative
02/04/2015EP2832732A1 Ppars agonist activity enhancing drug
02/04/2015EP2832731A1 Aromatic heterocyclic five-membered ring derivative having trpv4 inhibitory activity
02/04/2015EP2832730A1 Mirabegron-containing pharmaceutical composition
02/04/2015EP2832728A1 Triazinone compound and t-type calcium channel inhibitor
02/04/2015EP2832726A1 (2-heteroarylamino)succinic acid derivative
02/04/2015EP2832725A1 Aromatic ring compound
02/04/2015EP2832724A1 Nipecotic acid derivative and use thereof for medical purposes
02/04/2015EP2832722A1 Fused azole derivative
02/04/2015EP2832720A1 1,2-disubstituted cyclobutyl compounds
02/04/2015EP2832373A1 Method to block site-specifically chemokine-related inflammatory processes in vascular diseases and metastasis
02/04/2015EP2832370A1 Method for producing drugs and biologically active agents
02/04/2015EP2832369A1 Compositions for ameliorating and/or preventing adverse side effects in antibiotic therapy
02/04/2015EP2832367A1 Agent for preventing or treating giant cell tumor or chondrosarcoma arising in bone/soft tissue
02/04/2015EP2832360A1 Polysaccharide for use in preventing metastasis formation and/or relapse
02/04/2015EP2832359A1 Diquafosol-containing eye drop
02/04/2015EP2832358A1 Pharmaceutical kit for use in the treatment of colon and colorectal cancer
02/04/2015EP2832357A1 Selective AT2 receptor agonists for use in treatment of cachexia
02/04/2015EP2832356A1 Administration of a therapeutic amount of genistein to mitigate erectile dysfunction resulting from radiation therapy for prostate cancer
02/04/2015EP2832355A1 Anticancer agent
02/04/2015EP2832354A1 Semi-solid topical composition which contains pirfenidone and modified diallyl disulphide oxide (m-ddo) for eliminating or preventing acne
02/04/2015EP2832351A1 Multilayer Tablet Formulations Comprising Tenofovir and Entecavir
02/04/2015EP2832349A1 Lactate-based fulvestrant or fulvestrant derivative oily preparation and preparation method thereof
02/04/2015EP2832344A1 Composition, and external preparation for the skin or functional food each containing said composition
02/04/2015EP2831237A1 High molecular weight heparosan polymers and methods of production and use thereof
02/04/2015EP2831233A1 Compositions and treatments based on cadherin modulation
02/04/2015EP2831161A1 Fungicide formulations for plasticized pvc
02/04/2015EP2831160A1 Stable compositions of thiabendazole and iodine-containing fungicides
02/04/2015EP2831094A1 Computationally optimized broadly reactive antigens for h5n1 and h1n1 influenza viruses
02/04/2015EP2831083A1 Anti-inflammatory macrolides
02/04/2015EP2831081A1 Functionalized porous silicon nanoparticles and use thereof in photodynamic therapy
02/04/2015EP2831080A1 Lactam kinase inhibitors
02/04/2015EP2831079A1 Bicyclic heterocyclic derivatives as mnk1 and mnk2 modulators and uses thereof
02/04/2015EP2831077A1 Bicyclic pyrazinone derivatives
02/04/2015EP2831075A1 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
02/04/2015EP2831074A1 Novel pyrazolopyrimidines
02/04/2015EP2831073A2 Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b]pyridine compounds as modulators of c-met protein kinases
02/04/2015EP2831070A1 Process of preparing solifenacin or salt thereof, and novel intermediate used in the process
02/04/2015EP2831069A1 ISOXAZOLE beta-LACTAMASE INHIBITORS
02/04/2015EP2831067A1 Small molecule inhibitors of mcl-1 and uses thereof
02/04/2015EP2831066A1 Benzofuran derivatives for the treatment of hepatitis c
02/04/2015EP2831064A1 New indanyloxydihydrobenzofuranylacetic acid derivatives and their use as gpr40 receptor agonists
02/04/2015EP2831063A1 Schweinfurthin analogues
02/04/2015EP2831061A1 Triazole derivatives as hsp90 inhibitors
02/04/2015EP2831060A1 Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
02/04/2015EP2831056A1 New anti-mycobacterial drugs against tuberculosis
02/04/2015EP2831053A1 New indanyloxydihydrobenzofuranylacetic acid derivatives and their use as gpr40 receptor agonists
02/04/2015EP2831045A2 An improved process for the preparation of etoricoxib
02/04/2015EP2831043A1 Novel compounds for preventing and/or treating lysosomal storage disorders and/or degenerative disorders of the central nervous system
02/04/2015EP2831042A1 Heteroaryl compounds with a-cyclic bridging unit
02/04/2015EP2831041A2 Tcr/mhcii-collagen interaction inhibitors useful for the treatment of rheumatoid arthritis
02/04/2015EP2831039A1 Salicylic acid derivatives useful as glucocerebrosidase activators
02/04/2015EP2831034A1 Anti-metatstatic agents predicated upon polyamine-macrocyclic conjugates
02/04/2015EP2830712A1 Methods for modulating cell-mediated immunity using human milk oligosaccharides
02/04/2015EP2830666A1 Efficient synthesis of ethylenedicysteine-sugar conjugates for imaging and therapy
02/04/2015EP2830664A1 Administration of a raf inhibitor and a mek inhibitor in the treatment of melanoma
02/04/2015EP2830657A1 Treatment of acute inflammation in the respiratory tract
02/04/2015EP2830648A1 Methods for treating neoplasia
02/04/2015EP2830636A1 Pharmaceutical formulations comprising chondroitin sulfate and hyaluronic acid derivatives
02/04/2015EP2830635A1 Combination treatment comprising sulphated glycosaminoglycans for inducing labor
02/04/2015EP2830634A1 Method for treatment of labor arrest
02/04/2015EP2830633A1 Combination therapy for the treatment of cancer
02/04/2015EP2830632A1 Parenteral formulations for administering macrolide antibiotics
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 7860